Table 3.
MM Patients (n = 3002) |
Non-MM Patients (n = 5750) |
|
---|---|---|
Anti-hypertensive drug, n (%) | ||
All drugsa | 2141 (71%) | 4082 (71%) |
Diuretic | 1704 (80%)b | 3339 (82%)b |
ACE-I | 1113 (52%)b | 2180 (53%)c |
Calcium channel blocker | 1081 (50%)b | 1773 (43%)c |
ARB | 914 (43%)b | 1723 (42%)c |
Any other drugs | 53 (2%)b | 102 (2%)c |
ACE-I: angiotensin-converting enzyme inhibitor, ARB: angiotensin II receptor blocker, MM: multiple myeloma
aAll anti-hypertensive drugs included diuretics, ACE-I, ARBs, calcium channel blockers and other (alpha blockers, alpha-2 receptor agonists, beta-blockers, central agonists, combined alpha and beta blockers, peripheral adrenergic inhibitors, renin inhibitors and vasodilators)
bPercentage derived from n = 2141 MM patients treated for hypertension
cPercentage derived from n = 4082 non-MM patients treated for hypertension